Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment
Natsuko Onishi(City College of San Francisco), Savannah C. Partridge(University of Washington), Michael T. Nelson(Michigan Technological University), Bonnie N. Joe(University of California, San Francisco), Marina E. Giurescu, Jessica Gibbs(City College of San Francisco), Charlotte Dillis, Elise Berman, Hiroyuki Abé, Luminita A. Tudorica, John Kornak(University of California, San Francisco), Nola M. Hylton(University of California, San Francisco), Erin P. Crane(Georgetown University), Lara A. Hardesty, Mary S. Newell, Jennifer S. Drukteinis(Moffitt Cancer Center), Stefanie Woodard, Pulin Sheth, Theresa Kuritza, Bethany L. Niell, David C. Newitt(University of California System), Elizabeth S. McDonald(Hospital of the University of Pennsylvania), Despina Kontos(Faculty of 1000 (United States)), Linda Hovanessian‐Larsen(Los Angeles Medical Center), Dan Lopez Paniagua, Teffany Joy Bareng(University of California System), Patrick J. Bolan, An Church, Mohammad Eghtedari, Deepa Sheth, Laura J. Esserman(University of California, San Francisco), Heidi Umphrey, Elissa R. Price(University of California, San Francisco), Haydee Ojeda‐Fournier, Kathleen R. Brandt(Mayo Clinic), Kevin Morley, Neda Jafarian, Dulcy Wolverton, Kathryn Zamora(University of Alabama at Birmingham), Constance D. Lehman(Harvard University), Karen Y. Oh(Oregon Health & Science University), Wen Li(University of California, San Francisco), Kathleen Ward, Bruce A. Porter, Dae Hee Bang(University of California, San Francisco), Mark Rosen(California University of Pennsylvania), Kelly Fountain
Cited by 9
Related Papers
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
|CA A Cancer Journal for Clinicians|2007|2.6k
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
|JAMA Oncology|2020|707